Arbutus Biopharma Corp (ABUS): Shareholders' Equity
$76.58M
As of 2025-12-31
$258.73M
As of 2026-06-30
-17.6%
3-year compound annual growth
-5.6%
5-year compound annual growth
-17.9%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $76.58M | -21.4% | 2026-03-23, Balance as of period end |
| 2024-12-31 | $97.37M | -8.2% | 2026-03-23, Balance as of period end |
| 2023-12-31 | $106.02M | -22.5% | 2025-03-27, Balance as of period end |
| 2022-12-31 | $136.85M | -19.2% | 2024-03-05, Balance as of period end |
| 2021-12-31 | $169.44M | +66.2% | 2023-03-02, Balance as of period end |
| 2020-12-31 | $101.97M | +40.2% | 2022-03-03, Balance as of period end |
| 2019-12-31 | $72.74M | -63.7% | 2021-03-04, Balance as of period end |
| 2018-12-31 | $200.23M | +9.7% | 2020-03-05, Balance as of period end |
| 2017-12-31 | $182.47M | -10.1% | 2019-03-07, Balance as of period end |
| 2016-12-31 | $203.00M | -62.9% | 2018-03-16, Balance as of period end |
| 2015-12-31 | $547.68M | +522.1% | 2018-03-16, Balance as of period end |
| 2014-12-31 | $88.03M | +48.7% | 2017-03-22, Balance as of period end |
| 2013-12-31 | $59.19M | +44.7% | 2016-03-09, Balance as of period end |
| 2012-12-31 | $40.92M | +682.9% | 2015-03-13, Balance as of period end |
| 2011-12-31 | $5.23M | n/a | 2014-03-28, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | 2025-12-31 | $76.58M | -21.4% |
| Opus Genetics, Inc. (IRD) | 2025-12-31 | $15.35M | +128.3% |
| Pyxis Oncology, Inc. (PYXS) | 2025-12-31 | $53.41M | -55.8% |
| CV Sciences, Inc. (CVSI) | 2025-12-31 | $1.47M | -18.2% |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 2025-12-31 | $245.15M | +75.7% |
| Evommune, Inc. (EVMN) | 2025-12-31 | $205.57M | n/m |
| Emmaus Life Sciences, Inc. (EMMA) | 2025-12-31 | -$63.61M | n/m |
| uniQure N.V. (QURE) | 2025-12-31 | $198.90M | n/m |
| Prelude Therapeutics Inc (PRLD) | 2025-12-31 | $68.64M | -47.8% |
Compare ABUS, IRD, PYXS, CVSI side by side · Screen every company in Pharmaceutical Preparations ↗